PDF factsheet
      Z

renin inhibitor in heart failure for acute decompensated heart failure, clinical trials results

Aliskiren versus placebo
ASTRONAUT, 2013
NCT00894387
Aliskiren
versus
placebo
stable patients with heart failure, an LVEF <40% (mean 28%), and elevated natriuretic peptides who had been discharged from a heart-failure hospitalization an average of five days beforedouble blind
Follow-up duration: 6 months
North and South america, Europe, Asia

  Options


in first

in second

  Filter